HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evaluation of potential confounding by smoking in the presence of misclassified smoking data in a cohort study of workers exposed to acrylonitrile.

AbstractOBJECTIVES:
To evaluate the extent to which lung cancer mortality risk estimates in relation to acrylonitrile (AN) exposure may have been confounded by smoking in the presence of misclassified smoking data.
METHODS:
Subjects were 992 white men employed for three or more months between 1960 and 1996 at a chemical plant in Lima, Ohio. We used Monte Carlo-based sensitivity analysis to address possible confounding by smoking.
RESULTS:
In Monte Carlo simulations that accounted for the relationship between smoking and AN exposure, mean relative risks for lung cancer mortality in relation to AN exposure decreased and we observed somewhat less evidence of an exposure-response relationship.
CONCLUSIONS:
Our simulations suggest that the relationship between AN exposure and lung cancer mortality was positively confounded by smoking in the original Lima cohort study.
AuthorsSarah Downing Zimmerman, Gary M Marsh, Ada O Youk, Evelyn Talbot
JournalJournal of occupational and environmental medicine (J Occup Environ Med) Vol. 57 Issue 2 Pg. 146-51 (Feb 2015) ISSN: 1536-5948 [Electronic] United States
PMID25612297 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Air Pollutants, Occupational
  • Carcinogens
  • Acrylonitrile
Topics
  • Acrylonitrile (toxicity)
  • Air Pollutants, Occupational (toxicity)
  • Carcinogens (toxicity)
  • Case-Control Studies
  • Chemical Industry
  • Cohort Studies
  • Computer Simulation
  • Confounding Factors, Epidemiologic
  • Data Collection (standards)
  • Humans
  • Lung Neoplasms (etiology, mortality)
  • Male
  • Monte Carlo Method
  • Occupational Diseases (etiology, mortality)
  • Occupational Exposure (adverse effects)
  • Ohio (epidemiology)
  • Prevalence
  • Smoking (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: